Compare Aspen Aerogels Inc (ASPN) vs Freeport-McMoRan Inc (FCX) Price & Performance

ASPN trades at $6.15, up 0.16% today, with a bullish technical signal from moving averages and ADX. The company reported Q2 2026 revenue of $29.5M, up 81% sequentially, and provided optimistic Q3 guidance of $65-80M revenue. However, it remains unprofitable with a net income margin of -62.45% and negative ROE of -50.36% as of 2026 data. Recent news highlights a Supplier of the Year award from General Motors and a staged restart of its East Providence facility.

Outlook is mixed: strong analyst consensus (82.61% buy ratings) and projected revenue growth in energy-industrial and EV sectors support upside, but persistent losses, high RSI near 73, and negative cash flows pose significant risks. Investment appeal hinges on execution of guidance and path to profitability amid competitive and regulatory pressures.

FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.

The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.